# A Trial of HTI-1090 in Subjects With Advanced Solid Tumors

> **NCT03208959** · PHASE1 · COMPLETED · sponsor: **Atridia Pty Ltd.** · enrollment: 18 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** HTI-1090

## Key facts

- **NCT ID:** NCT03208959
- **Lead sponsor:** Atridia Pty Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-30
- **Primary completion:** 2018-11-01
- **Final completion:** 2019-01-23
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2022-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03208959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03208959, "A Trial of HTI-1090 in Subjects With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03208959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*